Synergistic Integration of Anti-Adhesive Barrier Membrane with Emerging Technologies

This inventive concept combines the patented anti-adhesive barrier membrane with distinct technologies, such as AI, IoT, blockchain, and novel materials, to create a more powerful system for biomedical applications, enhancing surgical outcomes and patient care.

The original patent disclosed an anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications. However, the membrane's potential was limited by its standalone functionality. This inventive concept addresses the need for a more comprehensive system by integrating the membrane with other technologies, thereby expanding its capabilities and improving its performance.

The inventive concept consists of synergistic combinations of the anti-adhesive barrier membrane with emerging technologies. For instance, the membrane can be integrated with an AI-powered surgical planning tool to predict optimal barrier placement and shape, minimizing tissue adhesion. Alternatively, the membrane can be combined with IoT sensors to monitor and respond to changes in surgical microenvironments, optimizing wound healing. Additionally, a blockchain-based system can be used to track and verify the origin, composition, and performance of the membrane. Furthermore, the membrane can be incorporated into a composite material with a novel, biodegradable, conductive polymer for enhanced electrical stimulation of tissue repair. Finally, the membrane can be integrated into a wearable device with a machine learning algorithm to predict and prevent surgical site infections.

The new claims introduce a synergistic combination of the anti-adhesive barrier membrane with distinct technologies, creating a more powerful system that enhances surgical outcomes and patient care. The inventive step lies in the unexpected integration of these technologies, which provides a novel and non-obvious solution to the limitations of the original patent.

Other embodiments of the inventive concept could include integrating the membrane with robotic-assisted surgery, using different types of sensors or machine learning algorithms, or incorporating the membrane into implantable devices. These variations would ensure broad conceptual coverage and expand the potential applications of the inventive concept.

The inventive concept has significant commercial potential in the biomedical industry, particularly in surgical and wound care applications. The target market includes hospitals, medical device manufacturers, and research institutions. The synergistic integration of the anti-adhesive barrier membrane with emerging technologies could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies adopting this technology.